BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 1788830)

  • 1. Poor fibrinolytic response to venous occlusion by different criteria in patients with deep vein thrombosis.
    Stegnar M; Peternel P; Keber D; Vene N
    Thromb Res; 1991 Nov; 64(4):445-53. PubMed ID: 1788830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Residual plasminogen activator inhibitor activity after venous stasis as a criterion for hypofibrinolysis: a study in 83 patients with confirmed deep vein thrombosis.
    Nguyen G; Horellou MH; Kruithof EK; Conard J; Samama MM
    Blood; 1988 Aug; 72(2):601-5. PubMed ID: 3135860
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hypofibrinolysis in patients with a history of idiopathic deep vein thrombosis and/or pulmonary embolism.
    Grimaudo V; Bachmann F; Hauert J; Christe MA; Kruithof EK
    Thromb Haemost; 1992 Apr; 67(4):397-401. PubMed ID: 1631786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Deficient t-PA release and elevated PA inhibitor levels in patients with spontaneous or recurrent deep venous thrombosis.
    Juhan-Vague I; Valadier J; Alessi MC; Aillaud MF; Ansaldi J; Philip-Joet C; Holvoet P; Serradimigni A; Collen D
    Thromb Haemost; 1987 Feb; 57(1):67-72. PubMed ID: 3109059
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic response to venous occlusion for 10 and 20 minutes in healthy subjects and in patients with deep vein thrombosis.
    Petäjä J
    Thromb Res; 1989 Oct; 56(2):251-63. PubMed ID: 2515609
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombosis after hip replacement. Relationship to the fibrinolytic system.
    Eriksson BI; Eriksson E; Gyzander E; Teger-Nilsson AC; Risberg B
    Acta Orthop Scand; 1989 Apr; 60(2):159-63. PubMed ID: 2471386
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reproducibility of fibrinolytic response to venous occlusion in healthy subjects.
    Stegnar M; Mavri A
    Thromb Haemost; 1995 Mar; 73(3):453-7. PubMed ID: 7667828
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 4G/5G polymorphism of PAI-1 gene promoter and fibrinolytic capacity in patients with deep vein thrombosis.
    Sartori MT; Wiman B; Vettore S; Dazzi F; Girolami A; Patrassi GM
    Thromb Haemost; 1998 Dec; 80(6):956-60. PubMed ID: 9869167
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Age dependence of blood fibrinolytic components and the effects of low-dose oral contraceptives on coagulation and fibrinolysis in teenagers.
    Siegbahn A; Ruusuvaara L
    Thromb Haemost; 1988 Dec; 60(3):361-4. PubMed ID: 3149043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fibrinolytic response to venous occlusion in healthy subjects: relationship to age, gender, body weight, blood lipids and insulin.
    Stegnar M; Pentek M
    Thromb Res; 1993 Jan; 69(1):81-92. PubMed ID: 8465277
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Baseline fibrinolytic state and the risk of future venous thrombosis. A prospective study of endogenous tissue-type plasminogen activator and plasminogen activator inhibitor.
    Ridker PM; Vaughan DE; Stampfer MJ; Manson JE; Shen C; Newcomer LM; Goldhaber SZ; Hennekens CH
    Circulation; 1992 May; 85(5):1822-7. PubMed ID: 1572039
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrinolytic activity in patients with idiopathic and secondary deep venous thrombosis.
    Harbourne T; O'Brien D; Nicolaides AN
    Thromb Res; 1991 Dec; 64(5):543-50. PubMed ID: 1808759
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Altered fibrinolysis in DVT: influence of site of sampling.
    Han P; Koay ES; Tsakok M; Aw TC; Wong LY; Pradhan M
    Thromb Haemost; 1988 Aug; 60(1):50-3. PubMed ID: 3142091
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fibrinolytic parameters in patients undergoing total hip replacement: relationship with the development of asymptomatic deep vein thrombosis and diagnostic usefulness of venous occlusion.
    Trotti R; Siragusa S; Rondanelli M; Chezzi L; Citterio A; Melzi d'Eril GV; Piovella F
    Haematologica; 1997; 82(2):178-81. PubMed ID: 9175322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial clustering of defective release of t-PA.
    Petäjä J; Rasi V; Vahtera E; Myllylä G
    Br J Haematol; 1991 Oct; 79(2):291-5. PubMed ID: 1958488
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Hypofibrinolysis after venous occlusion in patients treated with long-term hemodialysis].
    Opatrný K; Vít L; Opatrná S; Sulková S; Bodláková B
    Cas Lek Cesk; 1994 May; 133(11):346-9. PubMed ID: 8004664
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Familial hypofibrinolysis and venous thrombosis.
    Petäjä J; Rasi V; Myllylä G; Vahtera E; Hallman H
    Br J Haematol; 1989 Mar; 71(3):393-8. PubMed ID: 2495018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Tissue-type plasminogen activator after venous occlusion in pregnancy and puerperium.
    Stegnar M; Zore A; Novak-Antolic Z; Vovk N; Kruithof EK
    Thromb Haemost; 1993 Sep; 70(3):486-90. PubMed ID: 8259554
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fibrinolytic activity in retinal vein occlusion.
    Abu El-Asrar AM; Abdel Gader AG; Al-Amro S; Al-Momem AK
    Int Ophthalmol; 1997-1998; 21(6):343-8. PubMed ID: 9869344
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The role of the fibrinolytic system in deep vein thrombosis.
    Wiman B; Ljungberg B; Chmielewska J; Urdén G; Blombäck M; Johnsson H
    J Lab Clin Med; 1985 Feb; 105(2):265-70. PubMed ID: 3919125
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.